Clinical trials: Silicosis
Lung Diseases, Obstructive, Asbestosis
Specialized Center of Research in Occupational and Immunologic Lung Disease
The overall objective of the Center was to develop a scientific data base for the control and prevention of acute and chronic lung injury caused by the inhalation of a variety of agents in the workplace and in the environment.
- Conditions
- Lung Diseases, Obstructive, Asbestosis, Silicosis, Pneumoconiosis
- Trial name
- NCT00005280
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Silicosis, Silicotic Fibrosis (Massive) of Lung
Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials
Silicosis is the most prevalent occupational lung disease in low- and middle-income countries (LMICs) with "tens of millions" estimated to suffer from the disease according to the World Health Organization (WHO).
- Trial name
- STARSS (NCT05538299)
- Testing
- questionnaire, KAP
- Where
- Rwanda
- Volunteers
- 995 people
- Sponsor
- Samuel Hatfield
TB - Tuberculosis, Silicosis
KAP TB in Senior Management Officials of Companies With Increased Silica Exposure
The study was designed as a descriptive cross-sectional survey conducted between February and October 2022. Senior management officials were targeted because of their role in workplace policy and oversight.
- Conditions
- TB - Tuberculosis, Silicosis, Occupational Exposure, Occupational Health
- Trial name
- KAP TB (NCT07749872)
- Where
- Zambia
- Volunteers
- 118 people, healthy volunteers welcome
- Sponsor
- Centre for Infectious Disease Research in Zambia